- Home
- Products
- Customized FluoroAb™
- RTN4
- Anti-RTN4 MAb (Clone 1)-iFluor® 488 Succinimidyl Ester
Anti-RTN4 MAb (Clone 1)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9916)
This product is comprised of an Human Anti-RTN4 IgG4-kappa antibody (Clone 1) labeled with iFluor® 488 Succinimidyl Ester. iFluor® 488 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- RTN4
- Alternative Names
- RTN-X
- Overview
- Reticulon 4, also known as neurite outgrowth inhibitor or Nogo, is a protein encoded by the RTN4 gene in humans and has been identified as a neurite outgrowth inhibitor unique to the central nervous system . During nerve development, Nogo is mainly expressed by neurons and provides inhibitory signals for the migration and germination of CNS endothelial (tip) cells, thereby limiting the density of blood vessels. There are three isoforms: Nogo A, B and C. Nogo-A has two known inhibitory domains, including the N-terminal amino Nogo and Nogo-66, the latter constituting the molecular extracellular loop. Both Amino-Nogo and Nogo-66 are involved in the inhibition reaction, of which Amino-Nogo is a strong inhibitor of neurite outgrowth, and Nogo-66 is involved in the destruction of the growth cone.
Studies have shown that blocking Nogo-A during neuronal damage (from diseases such as multiple sclerosis) can help protect or restore damaged neurons. [9] The study of the mechanism of this protein provides great potential for the treatment of autoimmune-mediated demyelinating diseases and spinal cord injury regeneration. It has also been found that it is a key participant in this process, and physical exercise can enhance the learning and memory processes of the brain. also shows that Nogo-A has a negative regulatory effect on blood vessel growth and repair after ischemic stroke. In the experimental stroke mouse model, Nogo-A gene deletion and antibody-mediated blockage resulted in enhanced revascularization and functional recovery. In addition, anti-Nogo-A antibody treatment reduces vascular leakage, the main complication after stroke.
- Overview
- Human Anti-RTN4 IgG4-kappa antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 488 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 491/516
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD80 MAb (Clone 4)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13526)
- Anti-MS4A1 MAb (Clone 28)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13204)
- Anti-FGFR2 MAb (Clone 11)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12565)
- Anti-CCL2 MAb (Clone 3)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1096)
- Anti-C5 MAb (Clone 10)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS1675)
- Anti-ERBB2 MAb (Clone 25)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS554)
- Anti-ERBB3 MAb (Clone 10)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1258)
- Anti-MSLN MAb (Clone 5)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11585)
- Anti-VEGFA MAb (Clone 10)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15391)
- Anti-EpCAM MAb (Clone 13)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6363)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS9916. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-1739 | Anti-RTN4 (Atinumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-1742 | Anti-RTN4 (Ozanezumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-1746 | Anti-RTN4 (Ozanezumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-1740 | Anti-RTN4 (Atinumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-1736 | Anti-RTN4 (Atinumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
